Foghorn Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio11.617.9713.87643.151677.72
P/B Ratio-5.76-3.532381.228.764.93
Price/Tangible Book2381.228.764.93
Price/FCF1.39
Price/OCF1.38
Enterprise Value Ratios
EV/Revenue1.511.74612.132079.55
Profitability & Returns
Return on Equity (ROE)-2.25%-0.83%-0.95%
Return on Assets (ROA)-0.22%-0.20%-0.16%-0.16%-0.31%
Return on Capital Employed (ROCE)-0.46%-0.47%-0.34%-0.21%-0.29%
Leverage & Solvency Ratios
Debt/Equity-0.82-0.58459.880.600.56
Debt/FCF0.27
Liquidity Ratios
Current Ratio3.734.116.379.4410.12
Quick Ratio3.644.006.269.339.86
Efficiency Ratios
Asset Turnover0.080.100.040.000.00
Yield & Distribution Ratios
Earnings Yield-0.33%-0.36%-0.41%-0.12%-0.10%
FCF Yield-0.39%-0.44%0.72%-0.06%-0.07%
Buyback Yield-0.31%-0.01%-0.12%-2.36%-1.64%